First-line treatment with bortezomib rapidly stimulates both osteoblast activity and bone matrix deposition in patients with multiple myeloma, and stimulates osteoblast proliferation and differentiation in vitro
Thomas Lund, Kent Søe, Niels Abildgaard, Patrick Garnero, Per T. Pedersen, Tina Ormstrup, Jean-Marie Delaissé, Torben PlesnerVolume:
85
Year:
2010
Language:
english
Pages:
10
DOI:
10.1111/j.1600-0609.2010.01485.x
File:
PDF, 358 KB
english, 2010